Bristol-Myers agrees to buy ZymoGenetics for $885M
Forbes
AP , 09.07.10, 06:31 PM EDT Bristol-Myers Squibb Co. said Tuesday it will acquire biotechnology partner ZymoGenetics Inc. for $885 million in another move by a major drugmaker to boost its pipeline by snapping up a smaller developer.
Bristol-Myers Will Buy ZymoGenetics for $885 Million Bloomberg


ZymoGenetics Reaches End of Road in Seattle, Faces Likely Job Cuts Xconomy
Bristol-Myers Pays Up for ZymoGenetics TheStreet.com
New York Times (blog) -MarketWatch (press release) -Northwest innovation
all 207 news articles »

 

Comments

Post a Comment
* Your Name:

* Your Email:

(NEVER publicly displayed)
Website URL:
* Security Image:
Security Image Generate New
Copy the numbers and letters from the security image:
 
* Your Comment:
No HTML tags are permitted in comments.
By submitting, you agree with our Publishing Policy. Please note that we may publish your comment in other sections of this site.